TH and Parkinson disease: Importantly,the in vivo results demonstrated that RVG29-RBCm/Cur-NCs could amelioratemotor deficits in PD mouse models, reduce the loss of tyrosine hydroxylase-positive(TH+) neurons in the substantia nigra compacta (SNpc),and restore DA levels in the striatum.